Skip to content
A Blog by Biocon

A Blog by Biocon

  • Home
  • About Us
  • Biocon Biologics
    • Biosimilars
    • Biocon Biologics @ IDF Congress 2019
      • Speaker Profiles
    • Itolizumab (ALZUMAb®) : Highly Promising Therapy for Cytokine Release Syndrome (CRS) in COVID-19
  • Healthcare
  • Innovation
  • Disease Epidemiology
  • Vodcast
  • Bioconites Corner
    • Work From Home
    • Campaigns
      • Har Ghar Tiranga
      • Mother’s Day
      • Lupus Day
  • Policy
  • Comments Policy
  • Contact

'BioConversations'

PM Narendra Modi recognizes Biocon and other Corporates for Contribution towards the Yellow Line Metro

PM Narendra Modi recognizes Biocon and other Corporates for Contribution towards the Yellow Line Metro

Biocon Q1FY26 Earnings is well-positioned for contined momentum and sustained growth

Biocon Q1FY26 Earnings is well-positioned for contined momentum and sustained growth

In Conversation with Dr. Praveen Raj for IDF, Thailand

In Conversation with Dr. Praveen Raj for IDF, Thailand

December 5, 2017December 5, 2017 Biocon Biosimilar, Innovation

Biocon’s Landmark Achievement of First USFDA approval for Biosimilar Trastuzumab applauded by all including the Media

First Biosimilar Trastuzumab approved in the US

November 27, 2017December 5, 2017 Biocon Biosimilars, Disease Management, Healthcare, Innovation

‘KRABEVA®’s Unique ‘Qual-Check’ Mechanism Ensures Patients Get a Quality-Ascertained Product’: Suresh Subramanian

Mr. Suresh Subramanian, Senior Vice President & Head Branded Formulations, Biocon shares his views on how KRABEVA® can make a significant impact in the biosimilars space.

October 10, 2017 Biocon Uncategorized

Coping with Mental Stress at Workplace

Mental health is one of the biggest issues facing our society today. Stress at the workplace is unavoidable. Here are a few simple strategies that can not only help you do your job better but also improve facets of your personal life.

July 14, 2017July 19, 2017 Biocon Policy

GST to Foster Supply Chain Operational Efficiency

Prasad Deshpande, Vice President & Head, SCM, Biocon shares his views on the impact of GST on Supply Chain in Pharma Sector.

May 31, 2017July 19, 2017 Biocon Healthcare

Healthcare PR & It’s Challenges: Seema Ahuja speaks to Reputation Today

Seema Ahuja, VP & Global Head of Communications, Biocon speaks on Healthcare PR, key challenges faced by the Healthcare and Pharma businesses & how in-house communication teams manage and navigate regulatory issues.

May 3, 2017May 19, 2017 Biocon General

Award-Winning IP Team Makes Biocon Proud, Again!

BIOCON is awarded the “9th NATIONAL IPR AWARD FOR 2017” in the category “Top Indian Company for creating Global Brand” & also conferred with “WIPO USERS TROPHY”

April 5, 2017April 5, 2017 Biocon Policy

Digital India Can Propel Us to Double-Digit Growth

Kiran Mazumdar-Shaw shares her views on how #digitalindia can transform lives, boost growth & propel us to double digit growth.

March 2, 2017 Biocon Policy

Biocon: Creating Value through Incisive IP Strategy

Arshad Jamil, General Manager, IPR, Biocon talks about Biocon's IP strategy that is creating value by leveraging the potential of our innovative products & processes.

February 3, 2017February 3, 2017 Biocon Policy

A Balanced Budget That Plays It Safe

Kiran Mazumdar Shaw, CMD, Biocon shares her views on #Budget2017

January 12, 2017January 12, 2017 Biocon Human Resource, Policy

Strategic HR for Today’s Biotech M&As

Amitava Saha, Sr. VP & Head HR, Biocon shares his views on the role of Strategic HR in ensuring the success of today’s biotech M&As.

December 31, 2016December 30, 2016 Biocon General

A Bioconite Looks Forward to a Hope-filled New Year!

Wishing everyone a very Happy and Hopeful New Year 2017! 🙂

December 29, 2016January 2, 2017 Biocon Healthcare

How Diet Can Help You Win With Diabetes – Part 2

Diabetes & Diet FAQs: Geetha G H, dietitian, certified diabetes educator and sports nutritionist, answers your queries on how to fight diabetes with a balanced diet.

December 5, 2016December 5, 2016 Biocon Healthcare

Ideal Nutrition & Diet can help in “Winning With Diabetes”

What kind of food can a person with diabetes eat and what kind of food should be avoided? How important is diet management in diabetes management? Find your answers here..

November 17, 2016November 25, 2016 Biocon Healthcare

Join Our Conversation on Fighting Diabetes

Biocon in its endeavour to fight diabetes is organising a webinar to create greater diabetes awareness and sensitize people with diabetes on life style modifications that could help them lead healthier and happier lives. Join us in 2 interactive webinars on November 23rd & November 28th, 2016 and help #BeatDiabetes! Eat Healthy! Live Healthy!!

October 28, 2016November 3, 2016 Biocon Healthcare

#DetectToDefeat – Battle Cry in Breast Cancer Crusade

Breast cancer is the second most common cancer in the world and, by far, the most frequent cancer among women. Every 19 seconds someone is diagnosed with breast cancer and every 74 seconds someone dies from it!

October 22, 2016October 24, 2016 Biocon Biosimilars

‘Stand-out’ Quarter for Biocon’s Biologics Business

Biocon reported strong Q2FY17 results. Small Molecules, Biologics and Research Services businesses showed strong growth while it was a stand-out quarter for the Biologics business.

October 14, 2016October 14, 2016 Biocon Biosimilars

Realizing the Promise of Biosimilars in 2020

Part 2 – The potential financial benefits and better health outcomes from biosimilars use could spur their uptake in health systems globally.

October 3, 2016October 3, 2016 Biocon Innovation

Antimicrobial Resistance (AMR) – A global threat is here to stay!

Antimicrobial resistance (AMR) represents a global catastrophe that threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi.

Posts navigation

Older posts
Newer posts
Biocon Employees come together to sing our National Anthem to mark 75th Independence Day.

Itolizumab: Highly Promising Therapy for Cytokine Release Syndrome (CRS) in COVID-19

DCGI Approval for emergency use of Itolizumab in treatment of Covid-19

Follow Biocon Biologics

BBL-X
BBL-Li
BBL-fb
BBL-Inst

Follow Biocon

Search

Biocon Limited

20th KM, Hosur Road,
Electronic City,
Bangalore, India - 560 100
Email: contact.us@biocon.com
+91 80 2808 2808 / 91 80 4014 4014

Archives

DISCLAIMER

Please read our Disclaimer and Comments Policy before engaging on our blog!

Create a website or blog at WordPress.com
  • Subscribe Subscribed
    • A Blog by Biocon
    • Join 116 other subscribers
    • Already have a WordPress.com account? Log in now.
    • A Blog by Biocon
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar
 

Loading Comments...